Illumina Appoints Susan Tousi as Chief Commercial Officer and Dr. Alex Aravanis as Chief Technology Officer, Head of Research and Product Development

/in , /by

SAN DIEGO —  Illumina, Inc. (NASDAQ: ILMN) today announced that it is appointing Susan Tousi as Chief Commercial Officer (CCO), and Dr. Alex Aravanis as Chief Technology Officer (CTO), Head of Research and Product Development. “We’re fortunate to have Susan and Alex, two of the strongest leaders in the genomics industry, take on these large, […]

Read more →

Pacific Biosciences Further Expands Leadership Team with Appointment of Dr. Catherine Ball to Newly Created Position of Senior Vice President of Research

/in , /by

MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced the appointment of three new hires to its growing team. Dr. Catherine Ball joins the company as Senior Vice President of Research, Kathleen Lynch joins as Head of Global Government Affairs and Corporate Communications, […]

Read more →

QIAGEN Announces Creation of Scientific Advisory Board and Agenda for Annual General Meeting in June 2021

/in , /by

New Board to consult Managing Board and Supervisory Board on scientific developments to ensure QIAGEN remains at the cutting edge in the Life Sciences and Molecular Diagnostics A Supervisory Board committee is renamed to “Nomination & ESG Committee” as part of sustainability commitment with greater focus on Environmental, Social and Governance topics QIAGEN’s Annual General […]

Read more →

Eagle Genomics Adds 3 New US Advisory Board Members to its Global Panel

/in , /by

The successful British scale-up has attracted senior figures in international business development, pharmaceutical commercial strategy and nutrition innovation in San Diego, Cambridge Massachusetts, and New York to help shape the next phase of its worldwide growth. Cambridge, UK – May 11th, 2021 – Eagle Genomics, a pioneer in applying network science to biology, has announced the […]

Read more →

Quanterix Appoints Masoud Toloue as President of Quanterix and Diagnostics

/in , /by

Toloue brings deep expertise and industry acumen to lead the Company’s strategic expansion into diagnostics BILLERICA, Mass. — Quanterix Corporation (NASDAQ: QTRX), a company helping to transform healthcare with digital protein biomarker technology enabling precision health, today announced it has named Masoud Toloue to the position of President of Quanterix and Diagnostics, effective June 9, 2021. “We are excited to welcome […]

Read more →

Accellix Expands its Leadership Team

/in , /by

Accellix Inc. is pleased to announce that Terrance Gin is joining its leadership team as Vice President Global Operations effective immediately. Terrance brings over 30 years of management experience in IVD manufacturing, process and product development, clinical laboratory operations, quality assurance, capital improvement, facility, and EH&S. He was VP of Operations at Singulex in charge […]

Read more →

Biosero Appoints Ryan Bernhardt as Chief Commercial Officer

/in , /by

With a focus on commercial expansion, Biosero also names Ruth Petersen as Director of Marketing Biosero, Inc., developer of automation solutions that enable laboratories to make better decisions in less time using more data, today announced two key hires as it expands commercial operations. Ryan Bernhardt joins the company as Chief Commercial Officer, and Ruth […]

Read more →

IsoPlexis Appoints Siddhartha Kadia to its Board of Directors

/in , , /by

BRANFORD, Conn. — IsoPlexis, the leader in functional single-cell proteomics, today announced the appointment of Siddhartha Kadia to its Board of Directors. Dr. Kadia joins IsoPlexis’ Board of Directors with over 20 years of experience in evolving a combination of technology, life science and healthcare industries. Dr. Siddhartha Kadia previously served as the President of […]

Read more →